The 5 and 10-year distant recurrence- free survival rates were lower in the young patients (77%and 67% for young, 85% and 85% for elderly, p
📌 3 Key Takeaways
🎯
Objective & Hypothesis:OBJECTIVETo compare the tumor characteristics, treatment approaches, recurrence patterns and survival resultsrates of young and elderly patients with breast cancer.METHODSIn this study, Between between 2000-2013, a total of 779 patients were treated for breast cancer at nineradiation oncology departments were evaluated retrospectively.
📊
Key Findings & Data:Three-hundred eight-four of these patients were young (≤35 years), and 395 of those the patients were elderly (≥70 years).RESULTSYoung patients were more likely to present with aggressive tumor features.
💡
Conclusion & Impact:The 5 and 10-year distant recurrence- free survival rates were lower in the young patients (77%and 67% for young, 85% and 85% for elderly, p
🔬Design:Research Article
📍Scope:2000-2013 Verileri
⚙️Variables:Domain Parameters
Abstract
OBJECTIVETo compare the tumor characteristics, treatment approaches, recurrence patterns and survival resultsrates of young and elderly patients with breast cancer.METHODSIn this study, Between between 2000-2013, a total of 779 patients were treated for breast cancer at nineradiation oncology departments were evaluated retrospectively. Three-hundred eight-four of these patients were young (≤35 years), and 395 of those the patients were elderly (≥70 years).RESULTSYoung patients were more likely to present with aggressive tumor features. They were more often receivedcomprehensive lymphatic irradiation, tumor bed boost and intense chemotherapy. No difference was foundfor 5 and 10-year loco-regional recurrence- free survival rates were (96% and 93% for young, 97% and 97%for elderly). The 5 and 10-year distant recurrence- free survival rates were lower in the young patients (77%and 67% for young, 85% and 85% for elderly, p
🔖
Cite This Article
ARICAN, Z., YILDIZ, F., GÜLTEKİN, M., ÖZYİĞİT, G., AYDIN, B., AKKUŞ, B., SARI, S. Y., GÖRKEN, İ. B., ÖNAL, C., AKMANSU, M., ERPOLAT, Ö. P., GÜRSEL, B., ÖKSÜZ, D. Ç., ERGEN, Ş. A. (2022). The Comparision of Breast Cancer in the Young and Elderly Patients. Türk Onkoloji Dergisi, Cilt: 34 - Sayı: 3, 179–188. https://ajindex.com/articles/639199
Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011;61(2):69–90
Howlader N, Noone AM, Krapcho M, Miller D, Bishop K, Kosary CL, et al. SEER Cancer Statistics Review. 1975-2014. Available at: https://seer.cancer.gov/ csr/1975_2014/. Accessed, April 2017. Bethesda, MD: National Cancer Institute, 2017
Chung M, Chang HR, Bland KI, Wanebo HJ. Younger women with breast carcinoma have a poorer prognosis than older women. Cancer 1996;77(1):97–103
Beadle BM, Woodward WA, Tucker SL, Outlaw ED, Allen PK, Oh JL, et al. Ten year recurrence rates in young women with breast cancer by locoregional treatment approach. Int J Radiat Oncol Biol Phys 2009;73(3):734–44
Anders CK, Hsu DS, Broadwater G, Acharya CR, Foekens JA, Zhang Y, et al. Young age at diagnosis correlates with worse prognosis and defines a subset of breast cancers with shared patterns of gene expression. J Clin Oncol 2008;26(20):3324–30
Singh R, Hellman S, Heimann R. The natural history of breast carcinoma in the elderly: implications for screening and treatment. Cancer 2004;100(9):1807–13
Copson E, Eccles B, Maishman T, Gerty S, Stanton L, Cutress RI, et al. Prospective observational study of breast cancer treatment outcomes for UK women aged 18-40 years at diagnosis: the POSH study. J Natl Cancer Inst 2013;105(13):978–88
Fredholm H, Eaker S, Frisell J, Holmberg L, Fredriksson I, Lindman H. Breast cancer in young women: poor survival despite intensive treatment. PLoS One 2009;4(11):7695
Grumpelt AM, Ignatov A, Tchaikovski SN, Burger E, Costa SD, Eggemann H. Tumor characteristics and therapy of elderly patients with breast cancer. J Cancer Res Clin Oncol 2016;142(5):1109–16. 10.Nixon AJ, Neuberg D, Hayes DF, Gelman R, Connolly JL, Schnitt S, et al. Relationship of patient age to pathologic features of the tumor and prognosis for patients with stage I or II breast cancer. J Clin Oncol 1994;12(5):888–94. 11.Kurtz JM, Jacquemier J, Amalric R, Brandone H, Ayme Y, Hans D, et al. Why are local recurrences after breast-conserving therapy more frequent in younger patients? J Clin Oncol 1990;8(4):591–8. 12.de Kruijf EM, Bastiaannet E, Rubertá F, de Craen AJ, Kuppen PJ, Smit VT, van de Velde CJ, Liefers GJ. Comparison of frequencies and prognostic effect of molecular subtypes between young and elderly breast cancer patients. Mol Oncol 2014;8(5):1014–25. 13.Anders CK, Fan C, Parker JS, Carey LA, Blackwell KL, Klauber-DeMore N, et al.